Veterans Opioid Abuse Prevention Act

Bill: 115-hr-3832
Sponsor: full_name: Rep. Dunn, Neal P. [R-FL-2]
Introduced: 2017-09-26
Policy area: Armed Forces and National Security
Subjects: Drug trafficking and controlled substances

Drug, alcohol, tobacco use

Health information and medical records

Prescription drugs

Veterans' medical care
Latest action: action_date: 2018-05-22
text: Received in the Senate and Read twice and referred to the Committee on Veterans' Affairs.

Summaries:
action_date: 2017-09-26
action_desc: Introduced in House
text: <p><b>Veterans Opioid Abuse Prevention Act</b></p> <p>This bill directs the Department of Veterans Affairs (VA) to enter into a memorandum of understanding with a national network of state-based prescription drug monitoring programs under which VA health care providers shall query such network to support the safe and effective prescribing of controlled substances to patients who: (1) receive a prescription for a controlled substance for a period of 90 days or longer, and (2) are not receiving palliative care or enrolled in hospice care.</p> <p>Under such memorandum of understanding, VA health care providers practicing in: (1) a participating state shall query such network in accordance with the agreement between that state's prescription drug monitoring program and such network, and (2) a nonparticipating state shall query the network through the drug monitoring program of the closest participating state.</p>

action_date: 2018-05-18
action_desc: Reported to House with amendment(s)
text: <p><b>Veterans Opioid Abuse Prevention Act</b></p> <p> This bill permits any Department of Veterans Affairs licensed health care provider or provider delegate accessing data on behalf of such provider to query and receive data from the national network of state-based prescription drug monitoring programs to support the safe and effective prescribing of controlled substances to patients who: (1) receive a prescription for a controlled substance, and (2) are not receiving palliative care or enrolled in hospice care.</p> <p>Health care providers or delegates shall query the network in accordance with applicable Veterans Health Administration regulations and policies. No state may restrict providers or delegates from accessing the state's prescription drug monitoring program.</p> <p> No state shall deny or revoke the license, registration, or certification of a licensed provider or delegate on the basis that such provider or delegate has queried or received network data. </p>

action_date: 2018-05-21
action_desc: Passed House amended
text: <p><b>Veterans Opioid Abuse Prevention Act</b></p> <p> (Sec. 2) This bill permits any Department of Veterans Affairs licensed health care provider or provider delegate accessing data on behalf of such provider to query and receive data from the national network of state-based prescription drug monitoring programs to support the safe and effective prescribing of controlled substances to patients who: (1) receive a prescription for a controlled substance, and (2) are not receiving palliative care or enrolled in hospice care.</p> <p>Health care providers or delegates shall query the network in accordance with applicable Veterans Health Administration regulations and policies. No state may restrict providers or delegates from accessing the state's prescription drug monitoring program.</p> <p> No state shall deny or revoke the license, registration, or certification of a licensed provider or delegate on the basis that such provider or delegate has queried or received network data. </p>

tv_txt: I 115th CONGRESS 1st Session H. R. 3832 IN THE HOUSE OF REPRESENTATIVES September 26, 2017 Mr. Dunn (for himself, Ms. Tenney , Mr. Poliquin , Mr. Arrington , and Mr. Tonko ) introduced the following bill; which was referred to the Committee on Veterans' Affairs A BILL To direct the Secretary of Veterans Affairs to enter into a memorandum of understanding with the executive director of a national network of State-based prescription monitoring programs under which Department of Veterans Affairs health care providers shall query such network, and for other purposes.

1. Short title This Act may be cited as the Veterans Opioid Abuse Prevention Act . 2. Department of Veterans Affairs participation in national network of State-based prescription drug monitoring programs (a) Memorandum of understanding The Secretary of Veterans Affairs shall enter into a memorandum of understanding with the executive director of a national network of State-based prescription drug monitoring programs under which Department of Veterans Affairs health care providers shall query such network to support the safe and effective prescribing of controlled substances to covered patients. Under such memorandum of understanding— (1) Department health care providers practicing in a State that participates in such network shall query such network in accordance with the agreement between that State’s prescription drug monitoring program and such network in accordance with applicable Veterans Health Administration policies; and (2) Department health care providers practicing in States that do not participate in such network shall query such network through the drug monitoring program of the participating State that is in closest proximity to the State where the provider is practicing. (b) Covered patients For purposes of this section, a covered patient is a patient who— (1) receives a prescription for a controlled substance for a period of 90 days or longer; and (2) is not receiving palliative care or enrolled in hospice care. (c) Exception The memorandum of understanding under subsection (a) shall provide for an exception to ensure that Department health care providers are not obligated to comply with the provisions of the memorandum of understanding if such provisions are in violations of applicable State law. (d) Definitions In this section: (1) The term controlled substance has the meaning given such term in paragraph (6) of section 102 of the Controlled Substances Act ( 21 U.S.C. 802(6) ). (2) The term national network of State-based prescription monitoring programs means an interconnected nationwide system that facilitates the transfer of State prescription drug monitoring program data across State lines.

tv_txt: IB 115th CONGRESS 2d Session H. R. 3832 IN THE HOUSE OF REPRESENTATIVES AN ACT To amend title 38, United States Code, to provide for access by Department of Veterans Affairs health care providers to State prescription drug monitoring programs.

1. Short title This Act may be cited as the Veterans Opioid Abuse Prevention Act . 2. Department of VETERANS AFFAIRS participation in national network of State-based prescription drug monitoring programs (a) In general Chapter 17 of title 38, United States Code, is amended by inserting after section 1730A the following new section: 1730B. Access to State prescription drug monitoring programs (a) Access to programs (1) Any licensed health care provider or delegate of such a provider shall be considered an authorized recipient or user for the purpose of querying and receiving data from the national network of State-based prescription drug monitoring programs to support the safe and effective prescribing of controlled substances to covered patients. (2) Under the authority granted by paragraph (1)— (A) licensed health care providers or delegates of such providers shall query such network in accordance with applicable regulations and policies of the Veterans Health Administration; and (B) notwithstanding any general or specific provision of law, rule, or regulation of a State, no State may restrict the access of licensed health care providers or delegates of such providers from accessing that State’s prescription drug monitoring programs. (3) No State shall deny or revoke the license, registration, or certification of a licensed health care provider or delegate who otherwise meets that State’s qualifications for holding the license, registration, or certification on the basis that the licensed health care provider or delegate has queried or received data, or attempt to query or receive data, from the national network of State-based prescription drug monitoring programs under this section. (b) Covered patients For purposes of this section, a covered patient is a patient who— (1) receives a prescription for a controlled substance; and (2) is not receiving palliative care or enrolled in hospice care. (c) Definitions In this section: (1) The term controlled substance has the meaning given such term in section 102(6) of the Controlled Substances Act ( 21 U.S.C. 802(6) ). (2) The term delegate means a person or automated system accessing the national network of State-based prescription monitoring programs at the direction or under the supervision of a licensed health care provider. (3) The term licensed health care provider means a health care provider employed by the Department who is licensed, certified, or registered within any State to fill or prescribe medications within the scope of his or her practice as a Department employee. (4) The term national network of State-based prescription monitoring programs means an interconnected nation-wide system that facilitates the transfer to State prescription drug monitoring program data across State lines. (5) The term State means a State, as defined in section 101(20) of this title, or a political subdivision of a State. . (b) Clerical amendment The table of sections at the beginning of chapter 17 of such title is amended by inserting after the item relating to section 1730A the following new item: 1730B. Access to State prescription drug monitoring programs. .

Passed the House of Representatives May 21, 2018. Karen L. Haas, Clerk.

tv_txt: IIB 115th CONGRESS 2d Session H. R. 3832 IN THE SENATE OF THE UNITED STATES May 22, 2018 Received; read twice and referred to the Committee on Veterans' Affairs AN ACT To amend title 38, United States Code, to provide for access by Department of Veterans Affairs health care providers to State prescription drug monitoring programs.

1. Short title This Act may be cited as the Veterans Opioid Abuse Prevention Act . 2. Department of VETERANS AFFAIRS participation in national network of State-based prescription drug monitoring programs (a) In general Chapter 17 of title 38, United States Code, is amended by inserting after section 1730A the following new section: 1730B. Access to State prescription drug monitoring programs (a) Access to programs (1) Any licensed health care provider or delegate of such a provider shall be considered an authorized recipient or user for the purpose of querying and receiving data from the national network of State-based prescription drug monitoring programs to support the safe and effective prescribing of controlled substances to covered patients. (2) Under the authority granted by paragraph (1)— (A) licensed health care providers or delegates of such providers shall query such network in accordance with applicable regulations and policies of the Veterans Health Administration; and (B) notwithstanding any general or specific provision of law, rule, or regulation of a State, no State may restrict the access of licensed health care providers or delegates of such providers from accessing that State’s prescription drug monitoring programs. (3) No State shall deny or revoke the license, registration, or certification of a licensed health care provider or delegate who otherwise meets that State’s qualifications for holding the license, registration, or certification on the basis that the licensed health care provider or delegate has queried or received data, or attempt to query or receive data, from the national network of State-based prescription drug monitoring programs under this section. (b) Covered patients For purposes of this section, a covered patient is a patient who— (1) receives a prescription for a controlled substance; and (2) is not receiving palliative care or enrolled in hospice care. (c) Definitions In this section: (1) The term controlled substance has the meaning given such term in section 102(6) of the Controlled Substances Act ( 21 U.S.C. 802(6) ). (2) The term delegate means a person or automated system accessing the national network of State-based prescription monitoring programs at the direction or under the supervision of a licensed health care provider. (3) The term licensed health care provider means a health care provider employed by the Department who is licensed, certified, or registered within any State to fill or prescribe medications within the scope of his or her practice as a Department employee. (4) The term national network of State-based prescription monitoring programs means an interconnected nation-wide system that facilitates the transfer to State prescription drug monitoring program data across State lines. (5) The term State means a State, as defined in section 101(20) of this title, or a political subdivision of a State. . (b) Clerical amendment The table of sections at the beginning of chapter 17 of such title is amended by inserting after the item relating to section 1730A the following new item: 1730B. Access to State prescription drug monitoring programs. .

Passed the House of Representatives May 21, 2018. Karen L. Haas, Clerk

tv_txt: IB Union Calendar No. 527 115th CONGRESS 2d Session H. R. 3832 [Report No. 115–684] IN THE HOUSE OF REPRESENTATIVES September 26, 2017 Mr. Dunn (for himself, Ms. Tenney , Mr. Poliquin , Mr. Arrington , and Mr. Tonko ) introduced the following bill; which was referred to the Committee on Veterans' Affairs May 18, 2018 Additional sponsors: Mr. Rutherford , Mr. Bost , Mr. Knight , Mr. McKinley , Mr. Hultgren , Mr. Gibbs , Mr. Jones , Mr. Lewis of Minnesota , Mr. Austin Scott of Georgia , Mr. Walden , Mr. Faso , Mrs. Love , Mr. Byrne , Mr. Hudson , Mr. Latta , Mr. Allen , Mr. Coffman , Mr. Bucshon , Mr. Bergman , Mr. Valadao , Mr. Yoho , Mrs. Wagner , Mrs. Handel , Mr. Ferguson , Ms. Kuster of New Hampshire , Mr. Gianforte , Mr. Higgins of Louisiana , Mr. Kilmer , Mr. Marshall , Mr. Heck , Mr. Soto , Mrs. Hartzler , Mr. Lamb , Mr. Olson , Mr. Rouzer , and Ms. Sinema May 18, 2018 Reported with amendments, committed to the Committee of the Whole House on the State of the Union, and ordered to be printed Strike out all after the enacting clause and insert the part printed in italic For text of introduced bill, see copy of bill as introduced on September 26, 2017 A BILL To direct the Secretary of Veterans Affairs to enter into a memorandum of understanding with the executive director of a national network of State-based prescription monitoring programs under which Department of Veterans Affairs health care providers shall query such network, and for other purposes.

1. Short title This Act may be cited as the Veterans Opioid Abuse Prevention Act . 2. Department of VETERANS AFFAIRS participation in national network of State-based prescription drug monitoring programs (a) In general Chapter 17 of title 38, United States Code, is amended by inserting after section 1730A the following new section: 1730B. Access to State prescription drug monitoring programs (a) Access to programs (1) Any licensed health care provider or delegate of such a provider shall be considered an authorized recipient or user for the purpose of querying and receiving data from the national network of State-based prescription drug monitoring programs to support the safe and effective prescribing of controlled substances to covered patients. (2) Under the authority granted by paragraph (1)— (A) licensed health care providers or delegates of such providers shall query such network in accordance with applicable regulations and policies of the Veterans Health Administration; and (B) notwithstanding any general or specific provision of law, rule, or regulation of a State, no State may restrict the access of licensed health care providers or delegates of such providers from accessing that State’s prescription drug monitoring programs. (3) No State shall deny or revoke the license, registration, or certification of a licensed health care provider or delegate who otherwise meets that State’s qualifications for holding the license, registration, or certification on the basis that the licensed health care provider or delegate has queried or received data, or attempt to query or receive data, from the national network of State-based prescription drug monitoring programs under this section. (b) Covered patients For purposes of this section, a covered patient is a patient who— (1) receives a prescription for a controlled substance; and (2) is not receiving palliative care or enrolled in hospice care. (c) Definitions In this section: (1) The term controlled substance has the meaning given such term in section 102(6) of the Controlled Substances Act ( 21 U.S.C. 802(6) ). (2) The term delegate means a person or automated system accessing the national network of State-based prescription monitoring programs at the direction or under the supervision of a licensed health care provider. (3) The term licensed health care provider means a health care provider employed by the Department who is licensed, certified, or registered within any State to fill or prescribe medications within the scope of his or her practice as a Department employee. (4) The term national network of State-based prescription monitoring programs means an interconnected nation-wide system that facilitates the transfer to State prescription drug monitoring program data across State lines. (5) The term State means a State, as defined in section 101(20) of this title, or a political subdivision of a State. . (b) Clerical amendment The table of sections at the beginning of chapter 17 of such title is amended by inserting after the item relating to section 1730A the following new item: 1730B. Access to State prescription drug monitoring programs. .

Amend the title so as to read: A bill to amend title 38, United States Code, to provide for access by Department of Veterans Affairs health care providers to State prescription drug monitoring programs. .

May 18, 2018 Reported with amendments, committed to the Committee of the Whole House on the State of the Union, and ordered to be printed